Results 21 to 30 of about 7,165,349 (311)
Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016 [PDF]
, 2018 In 1997, the Swiss Blood Stem Cell Transplantation Group (SBST) initiated a mandatory national registry for all haematopoietic stem cell transplants (HCTs) in Switzerland.Bargetzi, M., Kurt Leibundgut, Passweg, J.R., Renner, Christoph, Chalandon, Yves, Leibundgut, K., Leibundgut, Kurt, Grazia Nicoloso de Faveri, Swiss Blood Stem Cell Transplantation Group, SBST, Thomas Pabst, Christoph Renner, Duchosal, M.A., Baerlocher, Gabriela M, Nair, Gayathri, Ansari, M., Renner, C., Passweg, Jakob R, Sabine Gerull, Hess-Kappas, Ursula, Schanz, U., Schmidt, Adrian, Jakob R. Passweg, Gerull, S., Adrian Schmidt, Pabst, Thomas, Tayfun Güngör, Yves Chalandon, Nair, G., Urs Hess, Antonia Müller, Chalandon, Y., Nicoloso de Faveri, G., Duchosal, Michel A, Müller, Antonia, Masouridi Levrat, Stavroula, Ansari Djaberi, Marc Georges, Masouridi-Levrat, Stavroula, Heim, D., Müller, A., Halter, J.P., Baldomero, H., Masouridi-Levrat, S., Gabriela M. Baerlocher, Bargetzi, Mario, Stussi, Georg, Georg Stussi, Dominik Heim, Jörg P. Halter, Schanz, Urs, Marc Ansari, Michel A. Duchosal, Baerlocher, Gabriela M., Helen Baldomero, Ansari, Marc, Güngör, T., Halter, Jörg P, Nicoloso de Faveri, Grazia, Baerlocher, G.M., Gayathri Nair, Schmidt, A., Pabst, T., Urs Schanz, Stussi, G., Gerull, Sabine, Güngör, Tayfun, Stavroula Masouridi-Levrat, Mario Bargetzi, for the Swiss Blood Stem Cell Transplantation Group (SBST), Baldomero, Helen, Heim, Dominik, Hess, U., Hess, Urs, Gerull S, Schmidt A, Baerlocher GM, Renner C, Hess U, Güngör T, Ansari M, Passweg JR, Bargetzi M, Halter JP, Nair G, Baldomero H, Nicoloso de Faveri G, Masouridi-Levrat S, Müller A, Pabst T, Stussi G, For The Swiss Blood Stem Cell Transplantation Group Sbst, Schanz U, Duchosal MA, Heim D, Chalandon Y, Leibundgut K +94 morecore +2 more sourcesOutcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma [PDF]
, 2004 We report the outcomes after reduced-intensity conditioning allogeneic stem cell transplantation (RIT) for non-Hodgkin lymphoma (NHL) in 88 patients (low-grade NHL [LG-NHL], n = 41; high-grade NHL [HG-NHL], n = 37; mantle cell lymphoma [MCL], n = 10 ...Mahendra, P, Smith, GM, Cook, G., Hatton, C., Tighe, J., Morris, E., Goldstone, A, Peggs, K., Cook, G, Mahendra, Premini, Hunter, A., Mackinnon, S, Milligan, D., Smith, G.M., Goldstone, A., Chopra, R, Hunter, A, Linch, D., Parker, A, Linch, D, Morris, E, Hunter, A.H., Milligan, D, Thomson, K, Parker, A., Peggs, K, Chopra, R., Thomson, K., Craddock, C., Hatton, C, Mackinnon, S., Milligan, Donald, Mahendra, P., Schey, S., Craddock, Charles; id_orcid, Craddock, C, Schey, S, Tighe, J +37 morecore +1 more sourceHematopoietic chimerism after allogeneic stem cell transplantation : a comparison of quantitative analysis by automated DNA sizing and fluorescent in situ hybridization [PDF]
, 2005 Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is performed mainly in patients with high-risk or advanced hematologic malignancies and congenital or acquired aplastic anemias.Wachowiak, Jacek, Tomasz Strabel, Peter Bader, Bader, Peter, Jólkowska, Justyna, Jacek Wachowiak, Michał Witt, Anna Pieczonka, Strabel, Tomasz, Pieczonka, Anna, Dariusz Boruczkowski, Boruczkowski, Dariusz, Justyna Jółkowska, Witt, Michal +13 morecore +2 more sourcesCell transplantation for diabetes [PDF]
Philosophical Transactions of the Royal Society B: Biological Sciences, 2005 For 30 years there has been experimental work aimed at transplanting islets for the treatment of diabetes with a view to curing the disease and preventing the secondary complications. Many technical difficulties were experienced, first in isolating the islets without damaging them, and second in finding a suitable place to inject them, but until ...openaire +2 more sourcesFLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
Turkish Journal of Hematology, 2018 Objective: This study aimed to evaluate DNMT3A exon 23 mutations and their prognostic impacts in the presence of NPM1 and FLT3 mutations in acute myeloid leukemia (AML) patients who underwent allogeneic hematopoietic stem cell transplantation (HSCT ...Majid Teremmahi Ardestani, Ahmad Kazemi, Bahram Chahardouli, Saeed Mohammadi, Mohsen Nikbakht, Shahrbano Rostami, Mahdi Jalili, Mohammad Vaezi, Kamran Alimoghaddam, Ardeshir Ghavamzadeh +9 moredoaj +1 more sourceFunctional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study
Frontiers in Immunology, 2023 In the current post-pandemic era, recipients of an allogeneic hematopoietic stem cell transplant (HCT) deserve special attention. In these vulnerable patients, vaccine effectiveness is reduced by post-transplant immune-suppressive therapy; consequently ...Corinna La Rosa, Flavia Chiuppesi, Yoonsuh Park, Qiao Zhou, Dongyun Yang, Ketevan Gendzekhadze, Minh Ly, Jing Li, Teodora Kaltcheva, Sandra Ortega Francisco, Miguel-Angel Gutierrez, Haris Ali, Salman Otoukesh, Idoroenyi Amanam, Amandeep Salhotra, Vinod A. Pullarkat, Ibrahim Aldoss, Michael Rosenzweig, Ahmed M. Aribi, Anthony S. Stein, Guido Marcucci, Sanjeet Singh Dadwal, Ryotaro Nakamura, Stephen J. Forman, Monzr M. Al Malki, Don J. Diamond +25 moredoaj +1 more sourceRegulation of boundary cap neural crest stem cell differentiation after transplantation [PDF]
, 2009 Success of cell replacement therapies for neurological disorders will depend largely on the optimization of strategies to enhance viability and control the developmental fate of stem cells after transplantation.Hjerling-Leffler, J, Aldskogius, Hakan, Wegner, M, Hjerling-Leffler, Jens, Kozlova, Elena N, Medvinsky, Alexander, Berens, C, Aldskogius, H, Kozlova, EN, Berens, Christian, Kanaykina, Nadezda, Sandelin, Martin, Schreiner, S, Wegner, Michael, Kanaykina, N, Sandelin, M, Liakhovitskaia, A, Medvinsky, A, Liakhovitskaia, Anna, Schreiner, Silke, Kanaykina, Nadegda,, Kozlova, Elena,, Aldskogius, Håkan,, Sandelin, Martin,, Berens, Christian, +24 morecore +1 more sourceRobust SARS-COV-2-specific T-cell immune memory persists long-term in immunocompetent individuals post BNT162b2 double shot
Heliyon, 2022 Background: A robust efficiency of mRNA vaccines against coronavirus disease-2019 has been demonstrated, however, the intended long-term protection against SARS-CoV-2 has been challenged by the waning humoral and cellular immunity over time, leading to a Anastasia Papadopoulou, Fani Stavridou, Maria Giannaki, Kiriaki Paschoudi, Fani Chatzopoulou, Eleni Gavriilaki, Grigorios Georgolopoulos, Achilles Anagnostopoulos, Evangelia Yannaki +8 moredoaj +1 more sourceA case-control study on cryopreserved versus non-cryopreserved strategies for autologous hematopoietic cell transplantation in multiple myeloma
Journal of Bone Marrow Transplantation and Cellular Therapy
Background: Autologous hematopoietic cell transplantation (aHCT) is a standard treatment for Multiple Myeloma (MM). The classic practice is with cryopreservation of the peripheral blood stem cells (PBSC) in the period from collection to infusion, but ...Byron Figueroa, Martin Ferrando, Sebastian Galeano, Gabriel Borelli, Eloísa Riva, Alberto Vásquez, Carolina Oliver, Rosanna De Giuda, Silvia Pierri, Leticia Martinez, Melanie Isern, Claudia Martinez, Romina Urrutia, Cristina Otero, Victoria Irigoín, Victoria Remedi, Martina Perdomo, María Mori, Regis Gai, Estefanía López, Virginia Marcalain, Camila Guidali, Laura Bello, Virginia Moraes, Lourdes Viano, Analía Olivera, Carina Lamela, Carla Ambrosini, Silvia Pisano, Juan Ferrari, Jimena Prieto, Raul Gabús, Pablo Muxí, Ana Inés Landoni +33 moredoaj +1 more source